Literature DB >> 10488365

Antibiotic use and infection in snakebite victims.

R S Blaylock1.   

Abstract

OBJECTIVES: To determine the incidence of infection in snakebite patients, the bacterial species involved, and the indication for antibiotics.
METHOD: A prospective trial was undertaken at Eshowe Hospital, KwaZulu-Natal, involving 363 snakebite patients (records available for 310 patients). It was protocol not to give antibiotics unless necrosis was present or anticipated. Bacterial species were identified from necrotic areas and abscesses. A swelling classification was devised.
RESULTS: The syndromic presentation included no clinical envenomation (12%), painful swelling (85%), weakness (1.8%), venom ophthalmia (0.6%) and other presentations (0.6%). There was 1 death, of an 11-year-old with gross swelling and thrombocytopenia. 15.2% of patients received antibiotics. Protocol was broken in 23 patients. None of the patients who did not receive an antibiotic became infected, and hospital stay was not prolonged in this group. Of 20 bacteria isolated, 18 were Gram-negative aerobic enterobacteriaceae. No anaerobes were cultured.
CONCLUSIONS: Antibiotics should be reserved for those snakebite patients with necrosis (< 10%) and should cover Gram-negative aerobic bacilli and Gram-positive aerobic cocci.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488365

Source DB:  PubMed          Journal:  S Afr Med J


  11 in total

1.  Assessment of Cultivable Oral Bacterial Flora from Important Venomous Snakes of India and Their Antibiotic Susceptibilities.

Authors:  Innus K Shaikh; Prashant P Dixit; Balasaheb S Pawade; Mugdha Potnis-Lele; Babasaheb P Kurhe
Journal:  Curr Microbiol       Date:  2017-07-21       Impact factor: 2.188

Review 2.  Microbiology of animal bite wound infections.

Authors:  Fredrick M Abrahamian; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Pattern of Use of Antibiotics Following Snake Bite in a Tertiary Care Hospital.

Authors:  Dhanya Sasidharan Palappallil
Journal:  J Clin Diagn Res       Date:  2015-08-01

4.  Envenomation by Trimeresurus stejnegeri stejnegeri: clinical manifestations, treatment and associated factors for wound necrosis.

Authors:  Liao-Chun Chiang; Wei-Jen Tsai; Po-Yu Liu; Cheng-Hsuan Ho; Hung-Yuan Su; Chih-Sheng Lai; Kuo-Lung Lai; Wen-Loung Lin; Chi-Hsin Lee; Yi-Yuan Yang; Uyen Vy Doan; Tri Maharani; Yan-Chiao Mao
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-09-18

5.  Bacteriology of Naja atra Snakebite Wound and Its Implications for Antibiotic Therapy.

Authors:  Yan-Chiao Mao; Po-Yu Liu; Dong-Zong Hung; Wei-Cheng Lai; Shih-Ting Huang; Yao-Min Hung; Chen-Chang Yang
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

6.  Shewanella infection of snake bites: a twelve-year retrospective study.

Authors:  Po-Yu Liu; Zhi-Yuan Shi; Chin-Fu Lin; Jin-An Huang; Jai-Wen Liu; Kun-Wei Chan; Kwong-Chung Tung
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

7.  Routine prophylactic antibiotic use in the management of snakebite.

Authors:  D D Tagwireyi; D E Ball; C F Nhachi
Journal:  BMC Clin Pharmacol       Date:  2001-11-02

8.  Oral bacterial flora of Indian cobra (Naja naja) and their antibiotic susceptibilities.

Authors:  Sujogya Kumar Panda; Laxmipriya Padhi; Gunanidhi Sahoo
Journal:  Heliyon       Date:  2018-12-17

9.  Oral Microbiota of the Snake Bothrops lanceolatus in Martinique.

Authors:  Dabor Résière; Claude Olive; Hatem Kallel; André Cabié; Rémi Névière; Bruno Mégarbane; José María Gutiérrez; Hossein Mehdaoui
Journal:  Int J Environ Res Public Health       Date:  2018-09-27       Impact factor: 3.390

10.  Wound Infections of Snakebites from the Venomous Protobothrops mucrosquamatus and Viridovipera stejnegeri in Taiwan: Bacteriology, Antibiotic Susceptibility, and Predicting the Need for Antibiotics-A BITE Study.

Authors:  Chih-Chuan Lin; Yen-Chia Chen; Zhong Ning Leonard Goh; Chen-Ken Seak; Joanna Chen-Yeen Seak; Gao Shi-Ying; Chen-June Seak
Journal:  Toxins (Basel)       Date:  2020-09-07       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.